LY3526318 is an orally active, selective TRPA1 antagonist (IC50=5-6µM). LY3526318 blocks TRPA1 channels, inhibits pain signal transduction mediated by the channel, and exerts analgesic activity. LY3526318 is mainly used in the research of chronic pain-related fields, such as diabetic peripheral neuropathy, chronic low back pain, and pain caused by osteoarthritis[1][2].
Molekulargewicht:
556.46
Reinheit:
99.92
CAS Nummer:
[1889218-34-1]
Formel:
C23H19F3N10O4
Target-Kategorie:
TRP Channel
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
